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Effects of Synthetic Blood Plasma on Calcium-dependent Dimerization of NCAD12 
Brent Treadway and Susan Pedigo 
Department of Chemistry and Biochemistry, University of Mississippi, University, MS 
38677 
Neural Cadherin (NCAD) is one of three Type 1 vertebral “classical” cadherins that 
function as the primary transmembrane component in cell-to-cell interactions at adherens 
junctions.  Adhesive interactions mediated by this protein are calcium dependent with 
three calcium-binding sites between each of its five extracellular domains.  NCAD is very 
important in many cell-to-cell interactions because of its function in development and in 
immune and neurological synapses.  Generally, in vitro studies of calcium dependent 
dimerization of NCAD are conducted in a nonphysiological buffer (NaCl + HEPES: SEC 
buffer).  In order to study dimerization in more physiologically relevant conditions, I 
created a synthetic blood plasma (SBP) that more closely mimics the conditions in the 
extracellular space in the human body.  Spectroscopic and chromatographic studies have 
shown that the stability, calcium binding affinity and dimerization properties depend 
upon the buffer conditions.  Thermal denaturation studies show that stability of NCAD12 
in SBP buffer is similar to that in SEC buffer.  Calcium binding studies show 
precipitation in SBP buffer, most likely due to the precipitation of calcium phosphate.  
The data also appear to show competition between Ca2+ and Mg2+ in SBP buffer.  
Analytical SEC studies indicate that there is a lower affinity of dimerization in SBP 
buffer compared to that in SEC buffer.  Further studies titrating NCAD12 with 
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magnesium to determine its effects on dimerization without the presence of calcium are 
necessary to understand the effect that magnesium has on dimerization.  In summary, the 
more complex environment in which dimerization occurs in vivo impacts the apparent 
properties of NCAD.  
(NSF MCB 0950494; Sally MacDonnell Barksdale Honors College) 
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CHAPTER 1 
INTRODUCTION 
 
Cadherins are a family of transmembrane glycoproteins that have attracted the 
attention of scientists in a wide range of fields as diverse as the biochemistry of cancer, 
neurology and infectious disease.  Cadherins are found on the surface of cells and are 
essential to the structure and function of adherens junctions and desmosomes1, particular 
types of cell-to-cell adhesions.  Of this larger group, there is a subgroup known as 
vertebrate or “classical” cadherins that is the best studied2.  Special interest in cadherin 
research began when scientists first realized aberrant expression is a marker for certain 
types of cancer3.  For example, in cells treated with epidermal growth factor, there is 
marked increase in the binding of E-cadherin and Arf6, a protein that acts as a tumor 
promoter and leads to more aggressive breast cancer4.  This thesis aims to address the 
adhesive properties of purified neural cadherin under more physiologically relevant 
conditions using a series of simplified analytical techniques.  In order to understand the 
factors that impact dimerization of N-cadherin, I will first introduce the details of the 
molecule itself, and then a brief literature review that introduces the myriad processes in 
which it participates.
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I. Structure  
Classical cadherins are characterized by three primary regions: an extracellular 
region, a transmembrane region and a cytoplasmic region (Figure 1A).  The extracellular 
region has 5 modular domains with very similar structures5.  Calcium binds between each 
successive domain and is necessary for cell adhesion6.  The transmembrane region is a 
simple single pass alpha helix comprised of hydrophobic amino acids.  The cytoplasmic 
domain is intrinsically disordered and adopts secondary and tertiary structure when it 
binds to intracellular factors such as P120 and β-catenin, factors that function to promote 
interactions with the actin cytoskeleton and regulate transcription7.  Thus, adhesion 
between cells creates tension in the cytoskeletal network which governs interactions with 
key factors that regulate cell physiology8, 9.  This issue will be discussed in the next 
section. 
NMR and X- ray crystallographic studies have determined the structure of the EC 
domains in the three most well studied members of the family, neural (N-)10, 11, epithelial 
(E-)12, 13 and placental (P-) cadherins.  These structures confirm that each modular 
extracellular domain is comprised of seven anti-parallel β-strands that are typically 
labeled A-G (Figure 1B).  Non-covalent interactions promote formation of a barrel shape 
(Figure 1C).  The A strand is at the N terminus and is separated into A* and A strands14.  
The A strand is H-bonded with the G strand (parallel sheet) while the A* strand interacts 
with the B strand (antiparallel sheet).  The separation between the A and A* strands is a 
Pro5-Pro6 sequence that breaks the ordered structure of the A strand. 
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Extracellular	  space	  
	  	  	  	  	  	  	  	  Cytoplasm	  
Figure	  1A:	  	  Schematic	  of	  structure	  of	  ‘classical’	  cadherins.	  	  Five	  EC	  domains	  with	  three	  calcium	  binding	  sites	  in	  between	  each	  successive	  domain.	  	  The	  N-­‐terminus	  of	  the	  protein	  is	  in	  EC	  domain	  1,	  the	  most	  distal	  domain.	  	  The	  C-­‐terminus	  is	  in	  the	  cytoplasmic	  domain,	  and	  associates	  with	  various	  cellular	  factors	  and	  indirectly	  with	  the	  actin	  cytoskeleton.	  
	  
Figure	  1B:	  	  Each	  of	  the	  five	  EC	  domains	  have	  seven	  anti-­‐parallel	  strands	  that	  fold	  to	  make	  a	  barrel	  shape.	  	  The	  topology	  of	  the	  stands	  is	  a	  Greek	  Key	  motif.	  	  The	  loops	  that	  connect	  the	  strands	  are	  at	  the	  top	  and	  bottom	  of	  the	  barrel	  domain	  and	  contain	  residues	  that	  chelate	  the	  calcium	  ions	  that	  bind	  at	  the	  interfaces	  between	  adjacent	  domains.	  	   Figure	  1C:	  	  Ribbon	  drawing	  of	  a	  modular	  EC	  domain	  of	  cadherin.	  	  In	  the	  order	  of	  A	  to	  G,	  the	  seven	  strands	  are	  colored	  Red,	  Orange,	  Yellow,	  Green,	  Blue,	  Cyan,	  and	  Purple.	  In	  this	  structure,	  only	  the	  A	  strand	  is	  shown	  due	  to	  problems	  with	  the	  crystallization.	  	  The	  A*	  strand	  is	  not,	  and	  is	  represented	  by	  a	  thin	  red	  line.	  Figure	  made	  from	  structure	  1edh.pdb15	  using	  PyMol16.	  
 
In between each of the EC domains (EC1-EC5) there are residues that chelate 
three calcium (Ca2+) ions.  We study the first two domains (EC12) in our lab because they 
are the smallest physiologically relevant unit capable of calcium-dependent dimerization.  
Without these ions present (apo condition), cadherin is locked into the closed monomer 
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form.  A closed monomer refers to the insertion of a critical tryptophan in the second 
position, Trp2, into its own hydrophobic pocket17.  This closed structure is also stabilized 
by an ionic interaction between the N-terminus and the side chain of Glu8918.  The 
binding of calcium to the monomer induces strain in the closed monomer19.  A 
conformational change is initiated in order to reduce this strain.  As two apposed 
protomers are brought into proximity, Trp2 is undocked from its hydrophobic pocket in 
EC1 and crosses over to dock into the hydrophobic pocket of its partner cadherin near the 
N-terminus of the A strand.  Once the strand swapped dimer is formed, the strain in the 
closed monomer is relieved19.  Thus equilibrium is established between the closed 
monomer and dimer forms and favors dimer in the presence of calcium.  In summary 
cell-cell adhesion through cadherin dimerization occurs through a strand-swapped 
structure that is favored by the binding of calcium (Figure 2).  The dynamic nature of the 
dimerization equilibrium is crucial for the plasticity of tissues where adherens junctions 
are located20.   
        
Figure 2: Cartoon shows domains 1 and 2.  Equilibrium of closed monomer with strand 
swapped dimer.  First calcium binds and induces strain in each monomer (darkened EC1 
domains).  Then two closed monomers must approach each other in order for dimer 
formation to occur.  In a closed monomer, W2 of a cadherin is in its own hydrophobic 
pocket.  Upon dimerization, it swaps into the partner’s hydrophobic pocket.  Also 
highlighted is a second tryptophan, Trp 113, which is located in EC2. 
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Without adhesive dimerization, cancer and metastasis can occur.  Understanding 
the physiological conditions and what effect changes in these conditions have on N-
cadherin during development and adult cell life are the first steps in curing what is now a 
mostly lethal disease.   
 In addition to its role in metastasis of cancer, N-cadherin has an important role in 
neurological function in that its presence marks a synapse as the site of Long Term 
Potentiation, the basis of memory21-26.  Monoclonal antibody studies on chicken embryos 
demonstrated that N-cadherin is located in neurons and especially present during the 
different developmental stages of the mesoderm and neural tissues27.  Given its 
importance in proper neurological function and in the metastasis of cancer, a brief review 
of relevant functional aspects of N-cadherin follows. 
 
II. Function  
 
Cadherins are differentially expressed in the embryo but rarely expressed at the 
same time or place in mature tissues.  For example, in vascular development, VE-
cadherin is localized to cell-cell junctions while N-cadherin is found at cell surfaces28, 29.  
In fact, both in vivo and in vitro studies have shown that these two proteins inhibit one 
another’s functions when expressed in the same cell lines30.  Up-regulation and down-
regulation between expression and function of specific cadherins allow for adherens 
junctions to function normally and to adapt to the changing needs of tissues.  I will 
highlight some of these later in this chapter.  Aberrant expression of E- and N-cadherin is 
a hallmark of cancer and metastasis29.   
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A. Where is N-cadherin found? 
 	   N-cadherin, a specialized type of cadherin normally found in neurons, is also 
found in muscle cells, endothelial cells and cells of the eye31.  It has also been found in 
cell-cell junctions in the endothelium of blood vessels.  In endothelial cells, knockdown 
experiments of N-cadherin caused growth arrest and loss of cell proliferation31.  Loss of 
these cells caused death in embryonic cells due to defects in the vascular wall32.  
Adhesion-perturbing antibody studies have shown that by stopping the specific adhesion 
functions of these proteins in chicken embryos, the expression of N-cadherin over E-
cadherin is key for the differentiation of nascent tissues into skeletal muscle33.  N-
cadherin is found much less commonly in adult cell lines, being “restricted to neural 
tissue, retina, endothelial cells, fibroblasts, osteoblasts, mesothelium, myocytes, limb 
cartilage, oocytes, spermatids and Sertoli cells”34.  Finally, in the eye, N-cadherin is a 
regulator of vascular permeability.  A loss of N-cadherin correlates to an increase in 
permeability in endothelium and corneal edema35.	  	  Like any protein, the function of N-
cadherin as an adhesion protein is regulated by multiple mechanisms.	  	  These can include 
other proteins or transcription factors that upregulate or downregulate its functions.   
B. Protein Control of N-cadherin 
 	   There are a number of examples of proteins that interact with the N-cadherin and 
are important for its function.  Protein control of N-cadherin is closely regulated 
throughout development and in mature tissues to ensure proper functioning and to 
eliminate aberrant expression.  One regulatory protein of N-cadherin found during 
embryonic development is intercellular adhesion molecule-2 (ICAM-2).  ICAM-2 is a 
transmembrane glycoprotein of the immunoglobulin superfamily that supports 
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homophilic adhesion by cadherins.  In knockdown studies of ICAM-2 by siRNA, it was 
shown that loss of ICAM-2 resulted in accumulation of N-cadherin at cell junctions and 
junctional stability decreased31.  There are also some inter-cadherin regulatory 
mechanisms found within this cycle.  Western blot analysis indicates that in ICAM-2 
negative cell lines, VE-cadherin expression lowers significantly at cell junctions while N-
cadherin accumulation at these locations rises.  Thus, while N-cadherin is normally found 
on cell surfaces, in the absence of VE-cadherin, it begins to localize at cell junctions31, 36.  
Thus, the N-cadherin function as a junctional protein is regulated by protein factors.  Due 
to the fact that N-cadherin is essential for proper junctional stability, as we will see in the 
next section, it is important that the level of N-cadherin is regulated at the transcriptional 
level. 
C. Transcription factor control of N-cadherin 
 Transcription factor control of cadherin during development determines which 
protein will be expressed and thus the development of specific tissues.  In Drosophila, 
two transcription factors, twist and snail, are important in the switching of expression 
from E-cadherin to N-cadherin in the mesodermal germ layer in order to orchestrate 
morphology changes in developing tissues.  In experiments with twist mutant cell lines, 
N-cadherin expression was not initiated causing aberrant development in the ventral side 
of twist mutant embryos when compared to wildtype twist flies37. While N-cadherin 
expression was initiated in snail mutants, the results did suggest that it was necessary for 
continued expression during and after gastrulation37.  Loss of either of these two 
transcription factors would lead to cell junction mutations and possibly death.  
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D. N-cadherin and Cancer 
 N-cadherin and others of the cadherin family are important to study because of 
their involvement in both cancer and cancer metastasis.  The relationship between 
cadherin mediated cell-cell adhesion and cancer has been of interest for approximately 
two decades.  The basic concept is that proper adhesion between cells leads to tension in 
the actin cytoskeletal network.  This tension ensures the sequestration of factors that 
mediate the connection between actin and cadherin, namely members of the catenin 
family38-40.  When β-catenin is released from adherens junctions when cells are no longer 
adherent, it migrates to the nucleus where it associates with transcription factors that lead 
to an upregulation of factors that promote cell proliferation41, 42.  Recent studies conducted 
with breast cancer cells show that there is an association between N-cadherin and 
fibroblast growth factor (FGFR-1) that leads to downstream increases in levels of matrix 
metalloprotease-9 (MMP-9) expression and thus tumor invasion.  When N-cadherin binds 
to FGFR-1, it is stabilized, and its localization at the cell surface increases.  Increased 
FGFR at the cell surface causes a continuous cycling of the MAPK-ERK pathway 
leading to MMP-9 expression and cell proliferation and invasion (Figure 3)43.  Studies 
have also shown that when retinal pigment epithelial cells (RPE) are transplanted from in 
vitro to in vivo conditions, there is a marked switch from E-cadherin expression to N-
cadherin expression.  This change corresponds to a change from a polarized epithelial 
phenotypic cell to one that is fibroblastic and invasive34.  These studies establish the 
importance of testing cells not only in an in vitro setting, but also in an in vivo setting.   
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Figure 3: Diagram of N-cadherin-FGFR binding that incurs downstream increase in 
MMP9 causing increased cell proliferation and invasion.  Once bound to N-cadherin, 
FGFR stabilizes and begins to localize on the cell surface.  This causes the cell to 
constantly run the MAPK-ERK cycle and downstream transcription factor changes. 
 
 
III. Goals  
 Our laboratory studies protein in vitro.  While reductionist approaches are useful 
for testing specific mechanistic hypotheses, it is important to address how in vivo 
conditions would impact our studies.  In vitro studies are those that mimic some of the 
body’s elements in a test tube using purified proteins.  These proteins are considered to 
be outside of their normal, or biological, environments.  My experiment focuses more on 
the natural, or in vivo, conditions that one would find in the human body.  While still 
using purified proteins, the solution that I created mimics the ions and buffer systems 
found in blood plasma.  Standard solution conditions for in vitro studies in our lab consist 
of 140 mM NaCl, 10 mM HEPES, pH 7.4, the standard calcium-free buffer that we use in 
Size Exclusion Chromatography experiments, hence the name SEC buffer.  Using this 
buffer as a starting point, experiments have been performed to determine calcium’s 
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effects on cadherin’s function as a cell adhesion molecule.  The only problem with using 
this type of minimal-component buffer is that in vivo there are more ions that might affect 
the linked equilibria of the stability of the apo state, the Ca2+ binding affinity and the 
formation of dimer.   
As outlined in Figure 2, the presence of other cations could affect the stability, 
calcium binding affinity and therefore the formation of dimeric structures.  I 
hypothesized that indeed these other ions such as magnesium and potassium would 
decrease N-cadherin’s affinity for calcium between EC1 and EC2 via competition for site 
occupancy.  By creating a synthetic blood plasma (SBP) according to instructions by 
Kokubo and Takadama44, I used various analytical methods to determine calcium-binding 
affinity in the presence of these other ions.  It is important to note that calcium was 
deliberately left out of the SBP buffer so its effects could be measured once added to a 
solution composed of both SBP and N-cadherin.   
Results will demonstrate the effect of in vivo solution conditions on N-cadherin 
stability, calcium binding affinity and dimerization properties. 
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CHAPTER 2 
MATERIALS AND METHODS 
 
I. Analysis of Protein Stock 
Graduate student Jennie Fan expressed and purified NCAD12 during the winter of 
2014-2105.  The protein concentration was reported to be 106 μM prior to 
characterization.  In order to assess the purity of the protein in my stock, I ran SDS-
PAGE 17% gel calibrated against a standard ladder.  The samples were a 1:1 mixtures of 
NCAD12 stock and 2x loading buffer,	  a	  buffer	  comprised	  of	  β-­‐mercaptoethanol,	  glycerol,	  bromphenol	  blue	  and	  a	  pH	  6.8	  buffer.  The gel was electrophoresed at 100 V 
for approximately 1 hour and then stained in Coomassie Blue and destained in 
methanol/Acetic Acid.  Each well had a different volume.  This allowed visualization of 
contaminating bands to assess protein purity.  The volumes were 2.5, 5.0 and 10.0 μL 
respectively (Figure 4).   
To confirm the concentration of the protein sample a spectrum was taken from 
350 nm to 200 nm using a UV-Vis spectrometer.  To correct the spectrum for background 
signal, the absorbance at 280 nm was offset corrected by subtracting the absorbance at 
333 nm.  To determine the protein concentration, the corrected absorbance was divided 
by the extinction coefficient at 280 nm (15,900 M-1cm-1)45 and the pathlength (1 cm) 
(Figure 5). 
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Figure 4: 17% SDS-PAGE gel of N-cadherin at different volumes.  On the left is 
a standard ladder to compare protein size.  The second lane is 2.5 μL NCAD12, 
followed by 5.0 μL and 10.0 μL, respectively.  The lower bands reflect some 
protein impurities. 
 
 
Figure 5: UV-
scan of NCAD12 
stock.  Note flat 
signal from 350 
to 310 nm 
indicating 
solution did not 
contain particles 
that scattered 
light.  The final 
concentration of 
the protein was 
found to be ~106 
uM.   
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II. Synthetic Blood Plasma Composition 
 Synthetic blood plasma (SBP) is designed to closely mimic the ion concentrations 
and pH of in vivo blood plasma, but it omits proteins such as serum albumin and other 
globulins.  In our lab, experiments on NCAD12 have been performed in SEC buffer 
comprised of 10 mM HEPES, 140 mM NaCl, pH 7.4; calcium is added during the 
experiment.  SBP buffer contains one extra divalent ion: magnesium.  The presence of 
magnesium might compete with calcium for the binding sites between EC domains and 
affect binding affinities and dimerization.  
Using the protocol suggested by Kubo and Takadama44, 1000 mL of synthetic 
blood plasma (SBP) was made at room temperature (~25°C).  A plastic container was 
used in order to stop precipitation due to interactions between the salts and glass.  
Starting with 700 mL of deionized water, the compounds in Table 1 were added in order.   
Table 1: Order and amounts of reagents added to make Synthetic Blood Plasma 
 
Order Reagent Amount Purity (%) Formula 
weight (g) 
Concentration 
in Solution 
(M) 
1 NaCl 8.035 g 99.5 58.4430 0.138 
2 NaHCO3 0.355 g 99.5 84.0068 0.004 
3 KCl 0.225 g 99.5 74.5515 0.003 
4 K2HPO4 
3H2O 
0.231 g 99.0 228.2220 0.001 
5 MgCl2 6H2O 0.311 g 98.0 203.3034 0.0015 
6 1M-HCl 39 mL    
8 Na2SO4 0.072 g 99.0 142.0428 0.00051 
9 Tris 6.118g 99.0 121.1356 0.051 
10 1M-HCl 0-5 mL    
 
It was important to allow each reagent to dissolve before adding the next reagent.  After 
the addition of reagent 8, a pH meter was used to monitor the pH of the solution after the 
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additions of Tris base and HCl.  The final pH was adjusted to 7.4 using HCl, and 
deionized water was added to 1000 mL final volume.  The final solution was not filtered. 
III. Determining Protein Stability by Using Thermal-Unfolding Studies 
 
 Protein stability was estimated from thermal unfolding studies monitored using an 
AVIV 202SF CD spectrometer.  Temperature was scanned from 20 °C to 90 °C. Data 
were acquired with a 5 second averaging time.  To test whether the presence of Ca2+ 
affected the stability of NCAD12, two studies were conducted: one apo and one with the 
addition of Ca2+ to a final concentration of 1 mM.  In both, the protein was diluted in SBP 
buffer to a final concentration of 5 μM.  Results from these experiments were then 
compared to similar experiments performed in SEC buffer (10 mM HEPES, 140 mM 
NaCl, pH 7.4).  These data were then fit to the Gibbs-Helmholtz equation.  This equation 
shows the correlation between ∆G and melting temperature (Tm).  ΔHm is the enthalpy of 
unfolding at the melting temperature and ΔCp is the corresponding heat capacity.   
∆𝐺 =   ∆𝐻! 1−    𝑇𝑇! + ∆𝐶! 𝑇 − 𝑇! − 𝑇𝑙𝑛 𝑇𝑇!  
 
IV. Determining Calcium Binding Affinities 
 
Binding affinities were determined by conducting calcium titrations monitored by 
both circular dichroism and steady state fluorescence emission.  Both the PTI fluorimeter 
and the CD spectrometer (AVIV 202SF CD) were started and lamps warmed up 
according to laboratory protocols.  Initial protein solution was prepared in SBP buffer by 
diluting the apo NCAD12 stock to 5 μM.  Titrations comprised 13 separate runs.  The 
first spectrum was under apo conditions prior to the addition of calcium.  The next three 
spectra resulted from additions of 2.5, 5.0 and 10.0 μL of 1 mM Ca2+, respectively.  
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These same volumes were repeated for 10 mM, 100 mM and 700 mM Ca2+ and spectra 
were taken at each point.  Results from calcium titrations performed in SBP were then 
compared to similar titrations performed in SEC buffer.   
For the fluorimeter, excitation wavelength was measured at 292 nm and the 
wavelength scan was from 300-420 nm.  The angle of excitation and emission polarizers 
was 54°.  All experiments were completed in a quartz cuvette with a 1cm path length 
with stirring as Ca2+ was added.  An identical titration experiment was performed and 
monitored by CD.  Spectra were taken between 300 and 200 nm.  Spectra were offset 
corrected and then the signal at 230 nm was plotted versus the calcium concentration in 
the sample.  These data were then fit to the Adair equation with adjustable endpoint 
slopes and intercepts where Ka is the average association constant for Ca2+ and ΔG is the 
standard free energy change for binding:  𝜃 = !!!!!!!!  ;   ∆𝐺° = −𝑅𝑇𝑙𝑛𝐾! 
Spectra were taken on the PTI fluorimeter with the addition of Mg2+ in order to 
determine its effects on protein binding affinity in the absence of Ca2.  A 1:20 dilution of 
protein to SBP was added in a 1 cm cuvette and then 1 mM Mg2+ was added then 
scanned.  This was compared to spectra of 1mM Ca2+.  These experiments did not yield 
any results due to the cuvette being improperly cleaned before use.  Instead of light 
scattering due to the tryptophan in NCAD12, light reflected off of chemical debris 
already present in the cuvette, skewing any data obtained.   
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V. Determining Dimerization of Protein in SBP 
 
 In order to assess assembly kinetics for NCAD12 in SBP buffer, analytical Size 
Exclusion Chromatography (SEC) experiments were conducted.  When Ca2+ is added, 
equilibrium is established between Msat and Dsat.  Upon the addition of EDTA, the Ca2+ is 
quenched and dimer is kinetically trapped as D*apo, a representation of the amount of Dsat 
present while Ca2+ is in solution.  Figure 6 shows a schematic of this process. 
 
Figure 6: Schematic of equilibrium established by addition of calcium to NCAD12.  
Upon addition of EDTA, calcium is quenched and NCAD12 is locked as a kinetically 
trapped dimer, D*apo.  This is an exact representation of the amount of Dsat before EDTA 
was added.  
 
 The first study conducted with a HPLC was to test dimerization of NCAD12 in 
SBP buffer at three different concentrations (106, 20 and 10 μM) against NCAD12 
diluted in the SEC buffer at a concentration of 20 μM.  First 0.5 mL of protein was 
dialyzed in 100 mL SBP with 1mM Ca2+.  Before each run 5 mM EDTA was added to 
quench the calcium, then I waited 20 min before injecting the sample onto the loop.  The 
first run was pure protein stock, the second had a 1:5 dilution of protein to SBP buffer 
and the third run was a 1:10 dilution of protein to SBP buffer.  The final run was a 1:5 
dilution of protein to SEC buffer to use as a control.   
Mapo Msat Dsat 
Mapo	  +	  D*apo Ca2+ 
EDTA 
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Two other separate studies were conducted using the HPLC.  In both, the HPLC 
used a mobile phase buffer composed of 140 mM NaCl, 10 mM HEPES, pH 7.4.  The 
first study was a control using the normal salt buffer to test in vitro solutions.  To prepare 
my protein stock, Ca2+ was added up to 1 mM to NCAD12 stock (solution 1).  Then a 
buffer composed of 1 mL salt buffer and 10 μL of 100 mM Ca2+ (solution 2) was made.  
The final solution (injecting solution) that was used to inject on the LC was a 1:5 dilution 
of solution 1 to solution 2 (50 μL of 1: 200 μL of 2).  Three runs were conducted after 
quenching the final solution with 5 mM EDTA for 15 minutes.  After quenching, 50 uL 
of solution was injected into the HPLC.  The chromatograms were then printed and the 
ratio of dimer to monomer was measured.  This ratio was used to compare to the second 
set of studies. 
The second set of tests followed the same protocol with few adjustments.  Instead 
of SEC added to form the first solution, 100 mM Ca2+ was added to 1 mL of SBP buffer. 
Also, EDTA was added to a final concentration of 8 mM to compensate for the added 
divalent ions.   
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CHAPTER 3 
RESULTS 
 
 The present work characterizes the effects that the extra divalent ion (Mg2+) found 
in synthetic blood plasma has on the dimerization properties of NCAD12.  First, the 
relative melting temperature and enthalpy were determined in SBP buffer to compare to 
similar experiments conducted in the presence of a standard assay buffer, SEC buffer.  
Second, simple chromatographic techniques were used to determine the binding affinity 
in the presence of more than one divalent ion.  Finally, dimer versus monomer 
percentages at different concentrations of protein in SBP buffer and the Kds of NCAD12 
in SEC and SBP buffers were compared using simple SEC techniques.  
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I. Determining Protein Stability by Using Thermal-Unfolding Studies 
Thermal-unfolding was monitored by CD spectrometry at 227 nm with protein 
concentration diluted to 5 μM.  Results are summarized in Figure 7 where CD signal was 
graphed against probe temperature.  Signal becomes more negative as the temperature is 
increased, indicating protein unfolding.  Two transitions are obvious.  The first is more 
cooperative with clear folded- and unfolded baselines.  The first transition results from 
the unfolding of EC2.  The second transition (indicating unfolding of EC1) is problematic 
in that there is no clear unfolded baseline and a very gradual almost linear trend 
indicating there is an intermediate state in the unfolding EC1.   
Quantitative analysis of the transition 1 (EC2) resulted in the parameters shown in 
the inserts in Figures 7a and 7b.  In the apo-state, the EC2 has a Tm of 46.5°C, and an 
enthalpy of unfolding equal to 67 ± 4 kcal/mol (Figure 7a).  The ΔG at 25 °C was 
calculated to be 3.6 kcal/mol in the apo-state.  Upon the addition of Ca2+, data show an 
expected increase of approximately 10°C in melting temperature  (57.7 ± 0.3 °C) and an 
enthalpy of unfolding of 73 ± 3 kcal/mol (Figure 7b).  The ΔG at 25 °C was calculated 
to be 6.3 kcal/mol in 1 mM Ca2+.  Similar experiments have been performed in the 
laboratory with SEC buffer as diluent rather than SBP buffer.  The data show 
approximately similar results with a Tm in apo conditions at 45°C and with Ca2+ added at 
59°C.  The calculated values for ΔG in both apo and Ca2+ conditions were independent of 
buffer composition.   
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A) 
 
B) 
 
Figure 7A: A CD run with a 1:20 solution of protein to SBP without added calcium.  
Figure 7B: A CD run with a 1:20 solution of protein to SBP with 1 mM Ca2+.  Resolved 
parameters from fits to Gibbs Helmholtz equation.  Enthalpy and Tm are markedly higher 
upon the addition of calcium.  For both studies, the ΔCp was fixed to 1 kcal/molK.   
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11. Determining Ca2+ Binding Affinities 
A. Ca2+ Binding Determined by CD 
A Ca2+ titration was performed by CD spectrometry to determine binding 
properties of NCAD12 in SBP.  CD signal at 227 nm was plotted against the 
concentration of Ca2+.  These data, collected at 225 nM, show a large increase in signal at 
0.1 mM Ca2+.  The signal then plateaus as the protein is saturated with calcium.  There is 
an apparent aberrant data point at around 10 mM Ca2+ that may be due to unnecessary 
movement of the cuvette that the solution was placed in as Ca2+ was being added (Figure 
8).  No precipitate was noticed in the cuvette.  The midpoint of this curve is ~ 2.5x higher 
than previously measured for calcium titrations of NCAD12 in SEC buffer46.  The 
transition is exceptionally cooperative.   
 
Figure 8: Data collected from a Ca2+ titration monitored by CD.  Possible outlier at high 
calcium concentration is likely due to precipitation of the protein.   
 
Data were analyzed by a simple binding model to assess the shift in the midpoint 
due to the environment created by SBP.  The free energy of unfolding was -5.3 ±0.3 
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kcal/mol, a value approximately 0.7 kcal/mol lower affinity than found for NCAD12 in 
SEC buffer46.  So, there was no apparent competition between the calcium and 
magnesium for the calcium binding sites.  The apparent cooperativity in the binding 
curve was greater than witnessed for NCAD12 in SEC buffer46.  
B. Ca2+ Binding Monitored by Steady State Fluorescence Emission 
 Ca2+ titrations monitored by fluorescence show different results than those 
monitored by CD.  The concentration of Ca2+ was plotted against the fluorescence signal 
at 333 nm (the wavelength of maximum emission in apo-state).  Precipitation was 
observed in the cuvette at the end of the titration, and a corresponding exceptionally 
cooperative transition that occurs at ~ 2 mM calcium added (Figure 9a).  It is interesting 
that this calcium titration of NCAD12 in SBP caused the protein to precipitate when the 
titration monitored by CD did not precipitate.   
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b) 
	  
	  
 Figure 9A:  Calcium titration in SBP at different concentrations running from 1 mM to 
700 mM.  Total of 17 runs were completed, with the additional four runs after protocol 
conducted in order to saturate the protein; the apparent saturation of the signal is an 
artifact due to the precipitation of protein.   
Figure 9B:  NCAD12 in SEC buffer (top) and SBP (bottom) at apo and approximately 1 
mM Ca2+ during titration.  The solid line indicates apo conditions and the dashed line 
indicates the Ca2+ added. 
 
Also reported in Figure 9 are the fluorescence emission spectra in the apo and 1 mM 
calcium added state in SEC (top) and in SBP (bottom) buffers (Figure 9B).  Notice that 
in both figures, adding calcium increases the fluorescence signal, but does not change the 
wavelength with maximum emission signal.  The maximum emission wavelength is the 
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same in SEC and SBP buffers.  The primary purpose of this figure is to illustrate the 
challenge of studying the calcium-binding affinity in SBP buffer; the signal difference 
between the apo and calcium-added state in SBP buffer (1.5 mM Mg2+) is negligible.  
However, it is important to note that there must be some magnesium binding to the 
protein because there is a difference in the signal change upon calcium binding when 
magnesium is present. 
III. Determining Dimerization of Protein in SBP 
A. Dilutions in SBP  
Protein dimerization as a function of ion presence was determined using 
analytical SEC.  This initial experiment investigated the breadth of solution and protein 
concentrations to look for a general effect on dimerization by SBP buffer and the normal 
concentration-dependent effect expected for this monomer/dimer equilibrium.  Data were 
graphed against the elution volume to determine relative amounts of monomer vs. dimer.  
First, the concentrated stock vs. the 1 to 5 dilution of this stock in SEC buffer were 
compared.  It is clear that dilution yielded a much lower level of dimer than the 
concentrated stock, as one would expect.  Second, the levels of dimer for the 1 to 5 
dilutions of stock in SBP buffer to that diluted in SEC buffer were compared.  There is 
higher percentage of dimer for the SBP buffer dilution, implying that SBP buffer 
promotes the formation of dimer relative to SEC buffer.  Finally, a 1:10 dilution for stock 
in SBP buffer has less dimer formation than a 1:5 dilution.  Relative percentages of dimer 
versus monomer were then calculated along with the Kd of each run (Table 3).  Results 
show that Kd for dimerization of NCAD12 in SEC buffer is about 20 μM, slightly higher 
affinity than the expected value of 25 μM. In SBP buffer, the Kd is around half that in 
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SEC buffer (Figure 10), indicating that dimerization in SBP buffer is higher affinity than 
in SEC buffer. 
 
Figure 10: LC data for dilutions in SBP and SEC buffers at different concentrations.  Red 
is the original protein stock at ~100 μM.  Green and yellow are diluted in SBP buffer to 
20 μM and 10 μM, respectively.  Black is the control and diluted in SEC buffer to 20 μM.   
 
 1:5 in SEC Stock 1:5 in SBP 1:10 in SBP 
Monomer (%) 75 45 63 76 
Dimer (%) 25 55 37 24 
Kd (μM) 22.3 18.2 10.8 11.7 
Table 3: Monomer and Dimer percentages determined from HPLC graph.  Then Kd was 
calculated using these two numbers.   
 
 
B. SEC Buffer plus Ca2+ Control Experiments 
 Protein dimerization studies in the presence of SEC buffer and Ca2+ were 
conducted by analytical SEC methods in order to have a control for comparison after 
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further studies.  Due to its larger size, dimer elutes first followed by the smaller 
monomer.  The data show that Runs 1 and 3 have similar percent dimer formation while 
Run 2 produced less percent dimer formation (Figure 11).  The average Kd is 44.9 ± 34.2 
μM. This phenomenon held true for subsequent experiments and needs further testing to 
determine the cause.  These data do show that in each run the percentage of dimer formed 
is less than that of monomer formed, replicating results previously obtained.  Average 
percent dimer as well as Kd were determined in order to compare to subsequent studies 
(Table 4). 
 
Figure 11:  Three LC runs at the same 1:5 dilution of NCAD12 protein stock to SEC. 
(salt) buffer with Ca2+.  The ridges at the 14 – 15 mL mark show protein impurities as 
they go through the column and can be ignored.  Run 1: 44.6% dimer, Run 2: 37.9%, Run 
3: 42.7% dimer. 
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NCAD12 in SEC Xd (%) Kd (μM) 
20 μM 39.5 ± 11.8 44.9 ± 34.2 
Table 4:  Percentage dimer and Kd for NCAD12 in SEC buffer.  The standard deviations 
are high since Run 2 has less dimer than either Run 1 or Run 3 for unknown reasons.  
 
C. SBP Buffer plus Ca2+ Experiments 
 Similar analytical SEC experiments to that mentioned above were reproduced in 
the presence of SBP buffer instead of SEC buffer as the sample buffer conditions.  
Consistent with data in experiments run with SEC buffer, there is a greater percentage of 
monomer than dimer.  The data do indicate that there is a slightly higher dimer 
percentage in SBP buffer than in SEC buffer, but not enough to reach statistical 
significance.  As in previous experiments, Run 2 has a much lower dimer peak than Runs 
1 or 3 for unknown reasons (Figure 12).  In SBP, Runs 1 and 3 are approximately equal.  
Relative dimer percentages and Kd were calculated to compare to SEC studies (Table 5). 
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Figure 12: Three LC runs composed of 1:5 dilutions of protein to SBP buffer. As the 
elution volume exceeds 14 mL, protein impurities began to surface and these data points 
can be ignored.  Run 1: 45.7% dimer, Run 2: 39.1% dimer, Run 3: 44.1% dimer.  
 
 
NCAD12 in SBP Xd (%) Kd (μM) 
20 μM 42.8 ± 3.6 31.1 ± 6.7 
Table 5: Percentage Dimer and Kd for NCAD12 in SBP buffer with Ca2+.  The standard 
deviations are high due to Run 2 having much lower dimer than either Run 1 or Run 3 
due to unknown reasons. 
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CHAPTER 4 
DISCUSSION 
 
 Cadherin, the transmembrane component of adherens junctions, is of interest to a 
broad range of molecular physiologists because of the role these adhesive structures play 
in a diverse range of processes.  As described in the Introduction, N-cadherin is of 
interest because of its role in excitatory synapses in tissue for which it is named, but also 
for its role in angiogenesis and cancer metastasis.  Our laboratory has devoted much 
effort toward uncovering the molecular mechanism by which dimerization occurs 
between two cells.  Recently completed work from our laboratory highlights the 
possibility that divalent cations other than calcium may interact with cadherin and impact 
the stability, calcium binding and dimerization properties of the molecule.  The studies 
reported here emerged from this interest in how extracellular perturbants affect protein-
protein interactions.  I have investigated the effect of a more in vivo –like environment on 
the structure and function of N-cadherin.  Table 1 shows that there are many different 
ions in Synthetic Blood Plasma (SBP).  The experiments reported in this paper show that 
there is indeed a difference in N-cadherin’s response between these two buffers, most 
likely due to the second divalent ion in SBP, magnesium.  These studies indicate that it is 
important to consider in vivo conditions when experimenting on cadherin in the future. 
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 There are three calcium-binding areas in between each domain in N-cadherin.  It 
is possible that by adding different divalent ions to the buffer, they can possibly compete 
for these binding areas and decrease the affinity NCAD12 has for Ca2+ ions.  Fluorescent 
emissions spectra indicate that there is competition between these two ions (Figure 9).  If 
there was no binding of magnesium to NCAD12, then the spectra in Figure 9B top and 
bottom should be the same, and they are not.  In addition, there is significant change in 
dimerization affinity of NCAD12 for calcium when 1 mM magnesium is present 
indicating that there is significant competition by magnesium for the calcium binding 
sites. 
 It has been shown that in the presence of the divalent ion calcium there is an 
increase in the stability of the dimer form of NCAD12 due to the release of stress in the 
structure19.  So, upon the addition of another divalent ion that could possibly compete 
with calcium, one would expect that there would be a change in the dimeric properties of 
NCAD12.  While it is not proven in this paper that is what takes place here, the fact that 
NCAD12 in the presence of magnesium has approximately half the dimer formation 
when Ca2+ is added is consistent with the hypothesis (Figure 10).  Further analytical SEC 
experiments to confirm these results must be conducted.  Figures 11 and 12 seem to 
contradict this assertion, but the standard deviations are too high to argue point or 
counterpoint.   
 The composition of SBP mimics the environment found in the human body, 
where N-cadherin is naturally found.  The complexity of ions, small metabolites and 
other proteins found in the blood most likely affects binding and dimerization of 
cadherins.  This set of experiments attempts to show that in the presence of a second 
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divalent ion, there is a reduction in the binding affinity of N-cadherin to Ca2+.  These 
studies represent the beginning of an important investigation of the broad range of 
environmental perturbants that cadherin might encounter in vivo.  Future studies, like a 
magnesium titration in the absence of calcium, will allow for a better interpretation of the 
data here and will further our understanding of how other divalent ions affect the 
biophysical properties of NCAD12.   
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